Blog
RSS FeedPosted by Michael Wonder on 23 Oct 2022
Could more medicines be recommended for routine commissioning rather than spending time in the Cancer Drugs Fund?
19 October 2022 - A new analysis commissioned by the ABPI suggests they could. ...
Posted by Michael Wonder on 30 Nov 2021
Over 600 people set to benefit from innovative lung cancer treatment within the Cancer Drugs Fund
30 November 2021 - More than 600 people could benefit from an innovative drug for a form of lung cancer ...
Posted by Michael Wonder on 16 Jan 2020
Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund
15 January 2020 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...
Posted by Michael Wonder on 25 Nov 2019
Boris Johnson pledges £500 million for cutting-edge medicine as PM plans to expand Cancer Drugs Fund to fight dementia and motor neurone disease
23 November 2019 - Prime Minister promises to give patients faster access to innovative medicines. ...
Posted by Michael Wonder on 20 Aug 2019
NICE’s track record in cancer drugs: the impact of the CDF and interim funding
20 August 2019 - Cancer drugs and the decisions made by the UK’s NICE have been subject to much scrutiny ...
Posted by Michael Wonder on 25 Jun 2019
Petition for national cancer agency gathers steam
25 June 2019 - A petition launched in support of a national cancer agency has so far gathered more than ...
Posted by Michael Wonder on 12 Jun 2019
The Cancer Drugs Fund in practice and under the new framework
12 June 2019 - The Cancer Drugs Fund was established in 2010 to improve access to treatments not routinely available. ...
Posted by Michael Wonder on 07 Apr 2019
NICE appraisal for BMS kidney cancer immunotherapy combination
5 April 2019 - NICE has issued a Final Appraisal Determination endorsing NHS use of an Opdivo (nivolumab) and Yervoy ...
Posted by Michael Wonder on 28 Mar 2019
Promising lung cancer treatment approved for Cancer Drugs Fund
28 March 2019 - A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, ...
Posted by Michael Wonder on 03 Jun 2018
Tesaro's ovarian cancer drug Zejula added to Cancer Drugs Fund
1 June 2018 - Tesaro's ovarian cancer drug Zejula (niraparib), the first PARP inhibitor shown to be effective in patients ...
Posted by Michael Wonder on 31 May 2018
Pfizer's Xalkori makes it onto Cancer Drugs Fund
31 May 2018 - NICE has published draft guidance recommending that Pfizer's Xalkori (crizotinib) to treat ROS1-positive advanced non-small-cell lung ...
Posted by Michael Wonder on 18 Mar 2018
NICE says OK to Keytruda for bladder cancer via the Cancer Drugs Fund
16 March 2018 - Becomes the first immunotherapy recommended for urothelial cancer after chemotherapy. ...
Posted by Michael Wonder on 08 Feb 2018
Once a day pill for ovarian cancer could be made available on the CDF
8 February 2018 - NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund ...
Posted by Michael Wonder on 07 Feb 2018
Patients to benefit from myeloma treatment through CDF deal
7 February 2018 - Up to 1,600 patients with multiple myeloma could benefit from a new oral pill after NICE recommends ...
Posted by Michael Wonder on 31 Jan 2018
CDF to save NHS £140m over five years
31 January 2018 - At least £140 million is expected to be released into the NHS over the next five ...